Breaking News

Charles River Laboratories Makes Two Divestitures

Sells RMS Japan and CDMO Sweden businesses for approximately $115 million.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Charles River Laboratories has divested its Research Models and Services operations in Japan (RMS Japan) and its gene therapy CDMO site in Sweden (CDMO Sweden) in two separate transactions.   RMS Japan Divestiture   On October 12th, the company completed the sale of its RMS Japan operations to The Jackson Laboratory (JAX) for approximately $63 million in cash, subject to customary closing adjustments.   The RMS Japan operations provide research models and associated services to support clients i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters